Research Paper Volume 13, Issue 7 pp 10289—10311

A novel immune-related prognostic signature in epithelial ovarian carcinoma

The efficacy of signature in diverse subtypes according to the differentiated expressed genes. (A–C) KM curve analysis of the high-risk and low-risk groups in “differentiated,” “immunoreactive,” and “mesenchymal” subtypes. (D) Time-dependent ROC curve analysis of the prognostic model in “differentiated,” “immunoreactive,” and “mesenchymal” subtypes.

Figure 6. The efficacy of signature in diverse subtypes according to the differentiated expressed genes. (AC) KM curve analysis of the high-risk and low-risk groups in “differentiated,” “immunoreactive,” and “mesenchymal” subtypes. (D) Time-dependent ROC curve analysis of the prognostic model in “differentiated,” “immunoreactive,” and “mesenchymal” subtypes.